Abstract: Various aspects of the present disclosure generally relate to wireless communication. In some aspects, a user equipment (UE) may receive information indicating a condition for a conditional handover, and an indication to communicate on a source cell after transmitting a message on a target cell, associated with the conditional handover, and before receiving an additional message on the target cell. The UE may transmit the message on the target cell responsive to the condition for the conditional handover being satisfied. Numerous other aspects are described.

Abstract: An ultrasound scanning control method applied to an ultrasound scanning device is provided. The ultrasound scanning device includes an execution mechanism. The execution mechanism includes a mechanical arm and a probe. The ultrasound scanning control method includes controlling the mechanical arm to drive the probe to move according to a set scanning trajectory for performing an ultrasound scanning detection on a part to be examined. Once an actual pressure value between the probe and the part to be examined in each control cycle is sensed using the force sensor, a pressure value between the probe and the part to be examined is controlled to be a constant value based on the actual pressure value.

Abstract: A wheel mechanism includes a fixing base, a wheel base, a wheel, a fixing tube and a gasket. The gasket is disposed around the fixing tube to prevent the wheel with the wheel base from moving up and down. The upper gasket may be disposed between the fixing base and the wheel base to prevent the fixing base and the wheel base from colliding with each other to generate noise. The lower gasket may be disposed between the wheel base and the fixing tube to prevent the wheel base and the fixing tube from colliding with each other to generate noise. Further, when the wheel base is pivotally connected to the fixing base by the rotating shaft, the invention may selectively dispose at least one resilient member between at least two of the fixing base, the wheel base and the rotating shaft to prevent the wheel from shimmying.

Abstract: Disclosed are a microgranular water-soluble fertilizer co-produced from potassium nitrate by tower melt and a method of preparing the same, which relate to the technical field of production of water-soluble fertilizers. The microgranular water-soluble fertilizer co-produced from potassium nitrate by tower melt is prepared from potassium nitrate concentrate, urea, industrial monoammonium phosphate, water-soluble ammonium polyphosphate, potassium sulfate, EDTA-Fe, EDTA-Zn, EDTA-Mn, boric acid and ammonium heptamolybdate. The microgranular water-soluble fertilizer product co-produced from potassium nitrate by tower melt has balanced and stable nutrients. The product is microgranular, has a smooth appearance, is less susceptible to agglomeration, is easy to be absorbed and utilized by crops, and contains a full range of nutrients. In addition, the product is produced by a process employing fully automatic dispensing equipment, which mainly integrates “dispensing, mixing and packaging” and is fully automated.

Abstract: Provided are methods and systems for determining score consistency.

Abstract: Provided are methods and systems for determining score consistency.

Abstract: The present invention relates to the inclusion complexes of butylphthalide, which is D, L-mixed or levorotatory, with cyclodextrin or cyclodextrin derivatives, to a process for their preparation and the use thereof. In the invention, the butylphthalide is complexed with cyclodextrin or cyclodextrin derivatives, preferably with hydroxypropyl-?-cyclodextrin in order to increase the water-solubility of butylphthalide, develop clinical solid or liquid formulations and improve the therapeutic effect of butylphthalide. The inclusion complex, in which the molar ratio of butylphthalide to cyclodextrin or cyclodextrin derivatives is in the range of 1:1-10, can be used to prepare infusion, injection, injectable powder, liquids for oral administration, syrup, tablets, granules, dispersible tablets and others.

Abstract: Provided are methods and systems for determining score consistency.

Abstract: The present invention relates to the inclusion complexes of butylphthalide, which is D, L-mixed or levorotatory, with cyclodextrin or cyclodextrin derivatives, to a process for their preparation and the use thereof. In the invention, the butylphthalide is complexed with cyclodextrin or cyclodextrin derivatives, preferably with hydroxypropyl-?-cyclodextrin in order to increase the water-solubility of butylphthalide, develop clinical solid or liquid formulations and improve the therapeutic effect of butylphthalide. The inclusion complex, in which the molar ratio of butylphthalide to cyclodextrin or cyclodextrin derivatives is in the range of 1:1-10, can be used to prepare infusion, injection, injectable powder, liquids for oral administration, syrup, tablets, granules, dispersible tablets and others.

Abstract: The present invention relates to the inclusion complexes of butylphthalide, which is D,L-mixed or levorotatory, with cyclodextrin or cyclodextrin derivatives, to a process for their preparation and the use thereof. In the invention, the butylphthalide is complexed with cyclodextrin or cyclodextrin derivatives, preferably with hydroxypropyl-?-cyclodextrin, in order to increase the water-solubility of butylphthalide, develop clinical solid or liquid formulations and improve the therapeutic effect of butylphthalide. The inclusion complex, in which the molar ratio of butylphthalide to cyclodextrin or cyclodextrin derivatives is in the range of 1:1-10, can be used to prepare infusion, injection, injectable powder, liquids for oral administration, syrup, tablets, granules, dispersible tablets and others.

Abstract: A method and apparatus to determine an optimum collimator angle of a multi-leaf collimator having an opening and multiple leaf pairs for closing portions of the opening to form a radiation beam arrangement having multiple radiation beam segments. The method and apparatus include application of a cost function to determine a collimator angle which provides for delivery efficiency and target conformity. The user can preferentially either selectively enhance delivery efficiency of the radiation beam arrangement, reducing a number of radiation beam segments and reducing a number of radiation beam monitor units required for delivery of the desired prescription, or selectively enhance conformity of the radiation beam arrangement to a target shape. The optimum collimator angle is then used for delivery of an optimized radiation beam arrangement to a patient by a radiation delivery device.